Tfo Tdc, LLC Biocryst Pharmaceuticals Inc Transaction History

Tfo Tdc, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	SELL	$4.89 - $7.65 $9,100 - $14,236	-1,861 Reduced 99.84%	3 $0
Q4 2023 Feb 12, 2024	BUY	$4.98 - $6.77 $9,267 - $12,598	1,861 Added 62033.33%	1,864 $11,000
Q1 2023 May 03, 2023	BUY	$7.94 - $11.84 $7 - $11	1 Added 50.0%	3 $0
Q4 2022 Feb 03, 2023	BUY	$10.5 - $14.2 $21 - $28	2 New	2 $0

278

172M

625K

739K

Ticker BCRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,944,992
Market Cap $1.43B
Description
BioCryst Pharmaceuticals, Inc., a biotechnology company, discovers novel, oral, and small-molecule medicines. The company markets peramivir injection, an intravenous neuraminidase inhibitor for the treatment of acute uncomplicated influenza under the RAPIVAB, RAPIACTA, and PERAMIFLU names; and ORLADEYO, an oral serine protease inhibitor to treat...

Get notified when there are updates to the investment portfolio of Tfo Tdc, LLC, based on Form 13F filings with the SEC.

Stay updated on Tfo Tdc, LLC with notifications on news.